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a b s t r a c t
The Middle East respiratory syndrome coronavirus (MERS-CoV) closely resembled severe acute
respiratory syndrome coronavirus (SARS-CoV) in disease manifestation as rapidly progressive acute
pneumonia with multi-organ dysfunction. Using monocyte-derived-dendritic cells (Mo-DCs), we
discovered fundamental discrepancies in the outcome of MERS‐CoV‐ and SARS-CoV-infection. First,
MERS-CoV productively infected Mo-DCs while SARS-CoV-infection was abortive. Second, MERS-CoV
induced signiﬁcantly higher levels of IFN-γ, IP-10, IL-12, and RANTES expression than SARS-CoV. Third,
MERS-CoV-infection induced higher surface expression of MHC class II (HLA-DR) and the co-stimulatory
molecule CD86 than SARS-CoV-infection. Overall, our data suggests that the dendritic cell can serve as an
important target of viral replication and a vehicle for dissemination. MERS-CoV-infection in DCs results
in the production of a rich combination of cytokines and chemokines, and modulates innate immune
response differently from that of SARS-CoV-infection. Our ﬁndings may help to explain the apparent
discrepancy in the pathogenicity between MERS-CoV and SARS-CoV.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The novel Middle East respiratory syndrome coronavirus
(MERS-CoV), previously also known as human coronavirus (HCoV)
EMC, was ﬁrst identiﬁed in a patient who died from severe acute
pneumonia and renal failure in Bisha, Saudi Arabia, in September
2012 (Chan et al., 2013b; Chan et al., 2012; de Groot et al., 2013;
Zaki et al., 2012). Although a zoonotic source has been suspected
in bats and camels, the deﬁnitive and intermediate animal
reservoirs have so far not been conﬁrmed, which may have partly
contributed to the continuing spread of the epidemic (Annan et al.,
2013; Chan et al., 2013c; Chan, K.H. et al., 2013; Lau et al., 2013;
Reusken et al., 2013; Woo et al., 2007, 2012). As of February 7th,
2014, a total of 182 laboratory-conﬁrmed cases of MERS-CoV
infection with 79 fatalities have been reported in the Middle East,
Europe, and Africa (WHO, 2014). The evolving outbreak has raised
global concern of a SARS-like epidemic particularly because of
their comparably protean clinical manifestations involving both
the respiratory tract and extrapulmonary tissues, and the unu-
sually high crude fatality rate among infected patients (Assiri et al.,
2013b; Chan et al., 2012; Guery et al., 2013; Memish et al., 2013).
These clinical observations corroborated with several key experi-
mental ﬁndings on the high pathogenicity of MERS-CoV. First,
MERS-CoV replicated more rapidly and showed a much broader
tissue tropism in-vitro than any other coronaviruses associated
with human infections including SARS-CoV (Chan et al., 2013a).
Second, using human lung epithelial cell line as a model, it was
shown that MERS-CoV induced a massive dysregulation of the
host transcriptome, which may prevent the host from mounting
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an optimal immune response (Josset et al., 2013). Third, the utiliza-
tion of dipeptidyl peptidase 4 (DPP4) instead of angiotensin-
converting enzyme 2 (ACE2; SARS-CoV and HCoV-NL63), amino-
peptidase N (HCoV-229E), and 9-O-acetylated sialic acid (HCoV-
OC43) as a functional receptor by MERS-CoV may also account for
the differences in the spectrum of organ involvement between
MERS and other human coronavirus infections (Du et al., 2013; Raj
et al., 2013). Finally, there is currently no speciﬁc anti-MERS-CoV
treatment proven to be effective in clinical trials, though myco-
phenolic acid, interferons, ribavirin, cyclosporin A, and an HR2
peptide have demonstrated in-vitro activities (Chan et al., 2013d;
de Wilde et al., 2013; Falzarano et al., 2013; Lu et al., 2014).
Despite these initial clinical and laboratory correlations, the
virulence of MERS-CoV has remained controversial especially after
a recent study which reported that most of the patients who
required hospitalization or died from MERS were elderlies with
comorbidities, speciﬁcally diabetes mellitus, hypertension, and
chronic renal, heart and lung diseases (Assiri et al., 2013b). In
contrast, healthy children and adults might be asymptomatic or
develop mild infection detected only during contact tracing (Assiri
et al., 2013b; Chan et al., 2013b). Furthermore, many MERS
patients developed extrapulmonary manifestations including
renal impairment, hepatic dysfunction, gastrointestinal symptoms,
coagulopathy, cytopenias, and pericarditis (Assiri et al., 2013a;
Chan et al., 2013b). The mechanisms by which these extrapul-
monary tissues are involved in MERS are incompletely understood.
MERS-CoV RNA was detected in mononuclear cells and stellate
cells in the mediastinal lymph nodes of infected rhesus macaques,
hinting the possibility of macrophage or dendritic cell involvement
(de Wit et al., 2013). More in-depth studies on the pathogenesis of
MERS-CoV are urgently needed to ascertain its virulence and
pathogenetic mechanisms for more accurate prediction of its
clinical behavior and better design of therapeutic options. Given
the ability of MERS-CoV to infect different human immune cell
lines including monocytes and T lymphocytes, we postulated that
it might also be able to infect dendritic cells (DCs), which are
potent antigen presenting cells (APCs) with instrumental roles in
linking the innate and adaptive immune systems. Although pre-
vious literatures suggested that SARS-CoV was unable to establish
a productive infection in DCs, we suspected that MERS-CoV might
be able to infect DCs in a more efﬁcient manner due to the wide
distribution of its cellular receptor DPP4 in human cells including
activated leukocytes (Raj et al., 2013).
DCs are key players of the innate immune system. As perhaps
the most potent APCs, DCs are capable of entering peripheral
tissues, taking up antigens, migrating to lymphoid tissues, and
activating helper T cells (Banchereau and Steinman, 1998; Steinman
and Banchereau, 2007). In this capacity, DCs play unique roles in
bridging the innate and the adaptive immunity and therefore
become important targets for microbial invasion. For instance, HIV
has evolved a number of mechanisms to exploit the function of
DCs for its own beneﬁt, including escaping from the immune
surveillance and facilitating cell-to-cell dissemination (Wu and
KewalRamani, 2006).
DCs are susceptible to SARS-CoV infection. However, as sug-
gested by a number of studies, the infection was either abortive
(Law et al., 2005; Tseng et al., 2005; Ziegler et al., 2005) or at low
level (Spiegel et al., 2006) and caused no adverse effect to cell
viability. Infection of DCs by SARS-CoV failed to trigger a strong
type I interferon (IFN) response but resulted in an up-regulation of
inﬂammatory cytokines and chemokines (Law et al., 2005; Tseng
et al., 2005). Functional activation of DCs by SARS-CoV has been
analyzed but the result was inconclusive as both activation
(Spiegel et al., 2006; Tseng et al., 2005) and absence of activation
(Ziegler et al., 2005) have been proposed. In the current study, we
used monocyte-derived DCs (Mo-DCs) as a system to recapitulate
MERS-CoV infection in DCs and we compared the results with that
of SARS-CoV-infected Mo-DCs. Our results revealed fundamental
differences in the replication kinetics of MERS-CoV and SARS-CoV
in infected Mo-DCs. In addition, we also demonstrated character-
istic changes in the pattern of cytokine/chemokine expression as
well as antigen-presenting function of infected Mo-DCs.
Results
Monocyte-derived-dendritic cells (Mo-DCs) were susceptible
to MERS-CoV infection
To determine whether primary human DCs are susceptible to
MERS-CoV infection, we infected Mo-DCs with MERS-CoV and
examined the expression of MERS-CoV nucleoprotein (NP) at
different time points post inoculation. Our data revealed that
MERS-CoV NP expression could be detected at 12 hours post
infection (hpi) (Fig. 1A). The signal for NP appeared to be
puncta-like and distributed in the cytoplasm of infected cells. At
48 hpi, the signal for NP was dramatically enhanced and was
detected throughout the cytoplasm of infected cells (Fig. 1B).
Mock-infected cells (Fig. 1C) as well as cells treated with pre-
immune sera (data not shown) both failed to display any signal for
NP. Our immunostaining study revealed that Mo-DCs were sus-
ceptible to MERS-CoV infection. The enhanced expression of NP at
48 hpi versus 12 hpi suggested that MERS-CoV not only infected
Mo-DCs but also continued viral transcription and translation in
these infected cells. In addition, the percent of Mo-DCs infected by
MERS-CoV was assessed by ﬂow cytometry and was determined to
be 12.6%71.2% at 48 hpi (data not shown).
MERS-CoV infection in Mo-DCs was productive
With the immunoﬂuorescence study described above, we
illustrated that MERS-CoV was capable of infecting DCs with
efﬁcient transcription and translation of the viral genome, which
was supported by the substantial increase in cellular NP expres-
sion (Fig. 1). To obtain a more comprehensive picture of the
kinetics of MERS-CoV infection in Mo-DCs, we infected Mo-DCs
with MERS-CoV and compared the results with that of SARS-CoV-
infected cells. Importantly, a 2-to-4 log increase in viral RNA in
both cell lysates (Fig. 2A) and supernatants (Fig. 2B) of MERS-CoV-
infected Mo-DCs was detected in samples from all donors. In stark
contrast, little or no increase in viral RNA was detected in the cell
lysates or supernatants of SARS-CoV-infected Mo-DCs, which
agreed with previous reports that SARS-CoV could infect but was
unable to propagate in Mo-DCs. We further assessed the infectivity
of viral particles released from infected Mo-DCs with TCID50
assays. Our results demonstrated that while low levels of infec-
tious particles were detected from the supernatants of SARS-CoV-
infected Mo-DCs, MERS-CoV-infected Mo-DCs consistently
released a considerable amount of infectious particles with a peak
at 24 hpi (Fig. 2C). Overall, our data suggested that MERS-CoV
could establish a productive infection in Mo-DCs.
MERS-CoV triggered stronger cytokine and chemokine response than
SARS-CoV in Mo-DCs
DCs are among the ﬁrst line of innate immune response and are
capable of producing a large number of cytokines and chemokines
upon microbial challenge (Banchereau and Steinman, 1998). We
examined the ability of MERS-CoV to trigger cytokine and chemo-
kine response in Mo-DCs and compared the results with that of
SARS-CoV-infected Mo-DCs. Mo-DCs were infected with MERS-
CoV or SARS-CoV at 2 TCID50 per cell for one hour and cell lysates
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were harvested at 0, 5, 10, 24, 48, and 72 hpi. The expression of
cytokine and chemokine genes was quantiﬁed with RT-qPCR and
normalized ﬁrst with GAPDH and then with the gene expression
from the mock-infected cells. Our data recapitulated the lack of
IFN-α and IFN-β induction in SARS-CoV-infected Mo-DCs. At the
same time, while MERS-CoV similarly failed to trigger the expres-
sion of IFN-β, it induced an up-regulation of IFN-α at the early
time points. As shown in Fig. 3A, SARS-CoV marginally up-
regulated the expression of IFN-γ and did not induce an up-
regulation of IL-12. On the other hand, MERS-CoV induced
signiﬁcantly higher expression levels of IFN-γ and IL-12 than
SARS-CoV. Pro-inﬂammatory cytokine TNF-α and IL-6 were simi-
larly up-regulated in MERS-CoV-and SARS-CoV-infected Mo-DCs.
The peak fold inductions for TNF-α and IL-6 were documented
between 10 hpi and 48 hpi and were at comparable levels for
MERS-CoV and SARS-CoV (Fig. 3A).
In parallel, we quantiﬁed the expression levels of a number of
representative inﬂammatory and chemotactic chemokines, including
IP-10, IL-8, MCP-1, MIP-1α and RANTES. The degree of induction by
MERS-CoV and SARS-CoV on IL-8, MCP-1, and MIP-1α were subtle
with comparable levels. In contrast, MERS-CoV induced signiﬁcantly
higher levels of IP-10 and RANTES than SARS-CoV in Mo-DCs (Fig. 3B).
MERS-CoV induced higher surface expression of antigen-presentation
and co-stimulatory molecules than SARS-CoV in Mo-DCs
Dendritic cells are professional antigen presenting cells that
play critical roles in bridging the innate and the adaptive immu-
nity. Upon activation by foreign pathogens, DCs prime naive T cells
and trigger antigen-speciﬁc T cell responses. We assessed the
degree of activation of Mo-DCs upon MERS-CoV or SARS-CoV
challenge by measuring the surface expression of MHC class I
Fig. 1. Detection of MERS-CoV nucleocapsid protein (NP) in MERS-CoV-infected Mo-DCs with immunoﬂuorescence staining. Mo-DCs were seeded on glass coverslips in
24-well plates at a density of 1105 cells per well and infected with MERS-CoV at 2 TCID50/cell for 1 h. Infected Mo-DCs were ﬁxed at 12 hpi (A) and 48 hpi (B) and processed for
immunostaining. MERS-CoV NP was detected with guinea pig anti-NP antibody followed by FITC-conjugated rabbit-anti-guinea pig IgG. The slides were mounted with a mounting
buffer that contained DAPI and examined with a Carl Zeiss LSM 710 microscope. Mock-infected Mo-DCs that were ﬁxed at 48 hpi are shown in panel (C).
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(HLA-ABC), MHC class II (HLA-DR), and co-stimulatory molecules
(CD40, CD86). Mo-DCs were infected with MERS-CoV or SARS-CoV
at 2 TCID50 per cell for one hour. At 48 hpi, the cells were
detached, ﬁxed, immunolabeled for surface makers for co-
stimulation (CD40, CD86), MHC Class I (HLA-ABC), MHC Class II
(HLA-DR), and analyzed with ﬂow cytometry. As shown in Fig. 4,
while the surface expression of CD40 and MHC Class I (HLA-ABC)
were not signiﬁcantly higher in MERS-CoV-infected Mo-DCs
compared with that of mock-infected or SARS-CoV-infected Mo-
DCs, the surface expression of CD86 and MHC Class II (HLA-DR)
were signiﬁcantly increased in MERS-CoV-infected Mo-DCs. Sum-
maries of the change in the mean ﬂuorescence intensity were
illustrated in the right panels. Intriguingly, little change in surface
expression of MHC and co-stimulatory molecules were observed
in SARS-CoV-infected Mo-DCs (Fig. 4). Taken together, our result
demonstrated that MERS-CoV was more capable of inducing
Mo-DC activation than SARS-CoV.
Discussion
Previous studies suggested that SARS-CoV could infect Mo-DCs.
However, there was a marked reduction in viral genome copy over
time and a notable absence of infectious progeny from the inoculated
cells, which indicated that the infection, if any, was at low level
(Spiegel et al., 2006) or was abortive (Law et al., 2005; Tseng et al.,
2005). The absence of SARS-CoV NP expression in Mo-DCs suggested
that the viral replication cycle was incomplete (Ziegler et al., 2005).
In our current study, we demonstrated conclusively that MERS-CoV
could productively infect Mo-DCs. First, the immunoﬂuorescence
study showed a progressive increase in NP signal in infected
Mo-DCs over time (Fig. 1). Second, the positive-strand viral genome
of MERS-CoV increased by 2-to-4 logs in the supernatants and cell
lysates of infected Mo-DCs (Fig. 2A and B). Third, TCID50 assays
performed using supernatants from MERS-CoV-infected Mo-DCs
demonstrated that MERS-CoV produced a substantial amount of
infectious virus particles with a peak production time at around
24 hpi (Fig. 2C). Clinically, patients who contracted MERS-CoV devel-
oped coagulopathy, multi-organ dysfunction and hematological
changes including lymphopenia, neutrophilia and thrombocytopenia.
The virus could be detected not only in the respiratory tract, but also
in the blood (Guery et al., 2013), urine (Drosten et al., 2013), and stool
(Drosten et al., 2013) of infected individuals, which strongly argued for
a systemic dissemination of the virus. In this regard, MERS-CoV-
infected DCs and monocyte-derived macrophages (MDMs) (Zhou et
al., 2013) could potentially serve as vehicles of dissemination and
facilitate the spread of the virus to the lymph nodes, where they
interact with T cells, and further worsen the cytokine/chemokine
storm, mimicking the scenario in SARS (Gu et al., 2005).
Currently, the exact reason of why MERS-CoV but not SARS-CoV
could productively infect DCs is unclear. Differential infection out-
come with MERS-CoV and SARS-CoV may be partially attributed to
the difference in the level of receptor expression. ACE2 (Li et al., 2003)
and DPP4 (Raj et al., 2013) are the functional receptors of SARS-CoV
and MERS-CoV in humans, respectively. Previous reports have sug-
gested that ACE2 is not expressed in monocytes or DCs (Law et al.,
2005). A separate group suggested that ACE2 could be detected by
Western Blots in MDMs and DCs but surface expression of ACE2
Fig. 2. Replication kinetics of MERS-CoV and SARS-CoV in infected Mo-DCs. Mo-DCs were infected with MERS-CoV or SARS-CoV at 2 TCID50 per cell for 1 h. Supernatants and
cell lysates were harvested at the indicated time points and processed for RNA extraction, reverse transcription, and quantitative PCR. The copy number of the positive-sense
viral genomic RNA are illustrated for cell lysate (A) and supernatant (B). The number of infectious particles was quantiﬁed with TCID50 assays (C). Data from three
representative experiments are shown.
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Fig. 3. Quantitations of cytokine and chemokine induction in MERS-CoV- or SARS-CoV-infected Mo-DCs. Mo-DCs were infected with MERS-CoV or SARS-CoV at 2 TCID50 per
cell for 1 h. At the indicated time points post infection, cells were lysed for RNA extraction, RT and qPCR to detect the mRNA expression level of antiviral and proinﬂammatory
cytokines (A) as well as a number of representative chemokines (B). Results were normalized to GAPDH and presented as fold change in gene expression in relation to mock-
infected Mo-DCs. Data represented the mean and SEM from at least ﬁve donors. Statistical analysis was performed between MERS-CoV- and SARS-CoV-infected Mo-DCs for
all time points in all panels using Student's t test. po0.05 was considered to be statistically signiﬁcant and is indicated by asterisk marks.
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could not be detected by ﬂow cytometry (Tseng et al., 2005). Our
own analysis by RT-qPCR showed that while Mo-DCs express
high level of DPP4, the expression level of ACE2 is marginal and is
close to the detection limit (unpublished data). In addition, SARS-
CoV uses DC-SIGN and L-SIGN as alternative receptors (Han et al.,
2007; Jeffers et al., 2004). DCs are known to express abundant
levels of C-type lectins, which facilitates their antigen-uptake
(Figdor et al., 2002). For instance, DCs internalize and sequester
HIV particles through DC-SIGN, which is exploited by HIV to
facilitate efﬁcient cell-to-cell trans-infection (Geijtenbeek et al.,
2000). A similar mechanism is also utilized by hepatitis C virus in
trans-infection of liver cells (Cormier et al., 2004). Therefore, it is
possible that while MERS-CoV infects DCs with virus production,
SARS-CoV is primarily sequestered by DCs. Further investigation
on this possibility will be necessary.
DCs are important stimulators of T cells and B cells for speciﬁc
immune responses. In addition, upon encountering pathogens,
DCs are capable of releasing a large number of cytokines and
chemokines. Infection of Mo-DCs by SARS-CoV did not induce up-
regulation of anti-viral interferons, IFN-α and IFN-β, but resulted in
the up-regulation of other pro-inﬂammatory cytokines and che-
mokines (Law et al., 2005; Tseng et al., 2005). Recent research
demonstrated that MERS-CoV failed to trigger anti-viral interferon
or pro-inﬂammatory innate immune response in primary human
airway epithelial cells and in cultured cells (Chan, R.W. et al., 2013;
Zielecki et al., 2013). In the current study, we reported that MERS-CoV
induced no IFN-β and marginal IFN-α expression in infected Mo-DCs.
MERS-CoV induced comparable levels of pro-inﬂammatory cytokine
IL-6 and TNF-α compared to SARS-CoV. In parallel, the expression
level of chemokine IL-8, MCP-1, and MIP-1α was subtle and was not
signiﬁcantly different between MERS-CoV- and SARS-CoV-infected
Mo-DCs. Most importantly, MERS-CoV triggered a signiﬁcantly higher
expression level of IFN-γ, IL-12, IP-10, and RANTES, compared to
SARS-CoV-infected Mo-DCs (Fig. 3). In SARS-CoV-infected patients,
viral replication was limited to the ﬁrst two weeks after symptom
onset, without continued widespread replication after this period
Fig. 4. Surface expression of antigen-presentation and co-stimulatory molecules in Mo-DCs infected with MERS-CoV or SARS-CoV. Mo-DCs were infected with MERS-CoV or
SARS-CoV at 2 TCID50 per cell for 1 h. At 48 hpi, cells were detached, ﬁxed, and labeled for speciﬁc cellular surface markers. The expression of surface markers was assessed
by ﬂow cytometry using a BD FACSCanto II ﬂow cytometer and the data was analyzed using FlowJo. The numbers in each panel represent mean ﬂuorescent intensity. The
ﬁlled curve represents the staining of isotype controls. Results in the right panels represent mean %MFI and SEM summarized from four independent experiments. Statistical
analysis was performed between all groups using Student's t test. po0.05 was considered to be statistically signiﬁcant and is indicated by asterisk marks.
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(Nicholls et al., 2006). On the other hand, a number of cytokines and
chemokines including but not limited to IFN-γ, IL-12, and IP-10 were
found to be highly up-regulated in SARS-CoV-infected patients even
after viral clearance (Huang et al., 2005; Jiang et al., 2005; Wong et al.,
2004). The resulting immune dysregulation including an IFN-γ
mediated cytokine stormmight have accounted for a large proportion
of SARS-associatedmortality (Huang et al., 2005). In the current study,
we showed that MERS-CoV induced signiﬁcantly higher expression
level of IFN-γ, IL-12, IP-10, and RANTES in infected Mo-DCs, compared
to SARS-CoV. While IP-10 and RANTES both recruit T cells, IL-12
mediates the differentiation of naive T cells into Th1 cells and
stimulates the production of IFN-γ from Tcells, representing a positive
feedback loop. Our data raised the possibility of an IFN-γ-induced, Th1
cell-mediated immunity and hyperactive inﬂammatory response in
MERS-CoV-infected patients causing severe diseases before host
adaptive immune response could be mounted.
In the capacity of professional antigen-presenting cells, DCs
capture and process both endogenous and exogenous antigens and
present the processed antigens through MHC class I or MHC class II
molecules. During DC maturation, antigen capturing, processing, and
presentation are accompanied with an increase in the surface
expression of co-stimulatory molecules, including CD40, CD80, and
CD86, which are critical for T cell signaling and activation. Previous
studies performed using SARS-CoV-infected Mo-DCs indicated that
while the expression of MHC class I was comparable in infected and
mock-infected cells, the expression of MHC class II and co-stimulatory
molecules (CD40, CD80 and CD86) were up-regulated (Spiegel et al.,
2006; Tseng et al., 2005), although conﬂicting results existed (Ziegler
et al., 2005). In this study we demonstrated that MERS-CoV induced
higher surface expression of MHC class II (HLA-DR), and co-
stimulatory molecule CD86 than SARS-CoV in infected Mo-DCs
(Fig. 4). Although only around 13% of Mo-DCs were infected by
MERS-CoV, it appeared that CD86 and HLA-DR were up-regulated in
a much larger proportion of cells, which could be a result of paracrine
signaling from the infected Mo-DCs to the un-infected cells since the
expressions of a number of key cytokines and chemokines were up-
regulated in MERS-CoV-infected Mo-DCs. As a result of the up-
regulated MHC class II (HLA-DR) and co-stimulation molecule CD86,
the robust activation of T cells may contribute to an exaggerated T cell
function, which may lead to more destruction of infected pulmonary
tissues when adaptive immune response is mounted later in the
course of illness. Alternatively, activated T cells also produce high
levels of inﬂammatory cytokines that may potentially aggravate the
cytokine cascade.
Taken together, our study demonstrated that MERS-CoV could
productively infect DCs, thereby giving itself an extra edge in
systemic dissemination over SARS-CoV. At the same time, MERS-
CoV induced higher expression of IFN-γ and IFN-γ-related cyto-
kines and chemokines in infected DCs than SARS-CoV with
comparable levels of TNF-α and IL-6 mRNA expression. In addition,
antigen-presentation and co-stimulatory molecules are higher up-
regulated in MERS-CoV-infected DCs than SARS-CoV-infected DCs.
Overall, our study may help to conﬁrm the high pathogenicity of
MERS-CoV and explain the protean clinical manifestation seen in
MERS. Further investigation on the underlying mechanisms will
aid in the development of effective therapy for MERS.
Materials and methods
Preparation of Mo-DCs
Healthy volunteer blood samples were collected from Hong
Kong Red Cross Blood Transfusion Service according to a protocol
approved by the Institutional Review Board of the University of
Hong Kong. Monocyte preparation and differentiation were
performed according to a well established protocol we described
previously (Chu et al., 2012). In brief, peripheral blood mono-
nuclear cells (PBMCs) were obtained from buffy coats after Ficoll
centrifugation and were allowed to adhere to plastic surface
coated with poly-D-lysine (Sigma Aldrich, Saint Louis, MO, USA)
for 1 h. Adherent monocytes were then differentiated into Mo-DCs
according to established protocols. Specially, the cells were treated
with RPMI-1640 media supplemented with 10% FBS, 100 ug/ml
streptomycin, 100 U/ml penicillin, 2 mM glutamine, 1% sodium
pyruvate, 1% non-essential amino acids, 10 ng/ml recombinant
human granulocyte macrophage colony-stimulating factor (GM-
CSF), and 10 ng/ml recombinant human interleukin-4 (IL-4) (R&D
Systems, Minneapolis, MN, USA) for differentiation into Mo-DCs.
The Mo-DCs were differentiated for 8 days before used for
infection, during which the media was replaced every 2 days.
Virus
SARS-CoV was cultured in FRhK-4 cells in serum free DMEM
supplemented with penicillin and streptomycin. MERS-CoV was
kindly provided by Dr. Fouchier's laboratory (Zaki et al., 2012) and
cultured in Vero cells in the same medium. Two to three days post
infection, supernatants were collected, aliquoted, and stored at
80 1C. 50% tissue culture infective dose (TCID50) assays were
performed to quantify viral titers.
Virus Infections
For infections, Mo-DCs were plated in 24-well plates and
infected with MERS-CoV or SARS-CoV at 2 TCID50/cell for one
hour at 37 1C. Supernatants and cell lysates were harvested at 0, 5,
10, 24, 48, and 72 hpi. For immunostaining, Mo-DCs were plated in
24-well plates on glass cover slips. The cells were infected with
MERS-CoV at 2 TCID50/cell. At 12 and 48 hpi, the cells were ﬁxed
with 4% paraformaldehyde and underwent immunostaining
procedures.
Quantiﬁcation of viral and cellular RNA transcript by RT-qPCR
Cellular RNA extraction, reverse transcription and quantitative
PCR were performed as we described previously (Zhou et al.,
2011). Supernatants from infected cells were extracted with the
PureLink Viral RNA/DNA mini kit (Life Technologies). Reverse
primers against the NP gene of MERS-CoV and SARS-CoV were
used to retrieve cDNA complementary to the positive strand of
viral genomes and Oligo(dT) was used to reverse transcribe
cellular cDNAs. The levels of cellular gene expressionwere normal-
ized to GAPDH and presented as fold change in gene expression of
infected Mo-DCs relative to that of mock-infected Mo-DCs. Speciﬁc
primer sequences are available upon request.
Immunoﬂuorescence staining
Mo-DCs cultured on glass cover slips were infected with MERS-
CoV at 2 TCID50 per cell for 1 h at 37 1C. At 12 and 48 hpi, cells
were ﬁxed in 4% paraformaldehyde, permeabilized, blocked, and
immunostained for MERS-CoV NP. MERS-CoV NP was detected
using guinea pig anti-NP antibody as we previously described
(Chan et al., 2013a; Zhou et al., 2013), followed by FITC-conjugated
rabbit-anti-guinea pig IgG (Life Technologies). Slides were
mounted with ProLong Gold antifade reagent with DAPI (Life
Technologies) and examined with a Carl Zeiss LSM 710
microscope.
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Flow cytometry
Mo-DCs were infected with MERS-CoV or SARS-CoV at 2 TCID50
per cell for 1 h at 37 1C. At 48 hpi, infected cells were detached with
10 mM EDTA, ﬁxed in 4% paraformaldehyde, and immunolabeled
with speciﬁc cell surface markers. APC-anti-human CD40, APC-anti-
human CD86, APC- anti-human HLA-ABC, APC-anti-human HLA-DR,
and APC-IgG isotype control were ordered from Biolegend (SanDiego,
CA, USA). For infectivity assessment, infected Mo-DCs were ﬁxed,
permeabilized, and immunolabeled ﬁrst with guinea pig anti-MERS-
CoV NP antibody as we previously described (Chan et al., 2013a; Zhou
et al., 2013), followed by FITC-conjugated rabbit anti-guinea pig IgG
(Life Technologies). The ﬂow cytometry was performed using a BD
FACSCanto II ﬂow cytometer (BD Biosciences, San Jose, CA, USA) and
data was analyzed using FlowJo (Tree Star, Inc).
Statistical analysis
Experimental results represented mean and SEM from at least
three different donors. Statistical comparison between the groups
was performed by Student's t-test using GraphPad Prism 6.
Differences were considered statistically signiﬁcant when po0.05.
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